Celularity (CELU) Total Debt (2018 - 2025)
Celularity (CELU) posted quarterly Total Debt of $9.6 million for Q4 2025, down 75.1% year-over-year from $38.4 million in Q4 2024, and up 123.23% quarter-over-quarter from $4.3 million in Q3 2025.
Celularity (CELU) Total Debt (2018 - 2025) Analysis & Trends
Celularity (CELU) has reported Total Debt for 5 consecutive years, with $9.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Debt fell 75.1% year-over-year to $9.6 million; the TTM figure through Dec 2025 stood at $9.6 million (down 75.1% YoY), while the FY2025 annual figure was $9.6 million, down 75.1% from the prior year.
- Total Debt advanced to $9.6 million in Q4 2025 per CELU's latest filing, from $4.3 million in the prior quarter.
- Across five years, Total Debt topped out at $39.3 million in Q3 2022 and bottomed at $4.3 million in Q3 2025.
- Historically, Total Debt has averaged $28.0 million across 4 years, with a median of $35.7 million in 2023.
- Annual changes were most pronounced in 2024 — Total Debt jumped 123.03% — and 2025, when it plunged 75.1%.
- Celularity's Total Debt stood at $37.6 million in 2022, then plunged by 54.2% to $17.2 million in 2023, then jumped by 123.03% to $38.4 million in 2024, then slumped by 75.1% to $9.6 million in 2025.
- Business Quant data shows CELU's Total Debt at $9.6 million in Q4 2025, $4.3 million in Q3 2025, and $39.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.79 Bn | 131.94 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.74 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.48 Bn | 60.29 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.32 Bn | 54.18 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.08 Bn | 36.98 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.81 Bn | 28.50 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.56 Bn | 26.40 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 9.34 Bn |
| 10 | Celularity | 21.36 Mn | 15.19 Mn | -3.27 Mn | 9.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.56 Mn |
| Sep 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 39.14 Mn |
| Mar 31, 2025 | 38.98 Mn |
| Dec 31, 2024 | 38.41 Mn |
| Dec 31, 2023 | 17.22 Mn |
| Sep 30, 2023 | 14.01 Mn |
| Jun 30, 2023 | 33.84 Mn |
| Mar 31, 2023 | 35.69 Mn |
| Dec 31, 2022 | 37.60 Mn |
| Sep 30, 2022 | 39.26 Mn |
| Dec 31, 2018 | 150,000.00 |